Sort
50,496 grants matching “lung cancer”
Molecular features impacting drug resistance in atypical EGFR exon 18 and exon 20 mutant non-small cell lung cancers and the development of novel mutant-selective inhibitors
$566,537John V. Heymach · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
Infections, immunity, and inflammation in cancer
$566,530Eric A Engels · Division Of Cancer Epidemiology And Genetics · ZIA · FY2017 · CA
Persistence and regression in lung premalignant lesions
$566,523Meredith A Tennis · University Of Colorado Denver · R01 · FY2025 · CA
MOLECULAR EPIDEMIOLOGY OF LUNG CANCER
$566,492Chu Chen · Fred Hutchinson Cancer Research Center · R01 · FY2006 · CA
Quantifying and Characterizing the shared genetic contribution to common cancers
$566,464Sara Lindstroem · University Of Washington · U01 · FY2017 · CA
Molecular and Genetic Analysis of Lung Cancer Survival
$566,437David C Christiani · Harvard School Of Public Health · R01 · FY2011 · CA
Characterizing blood progenitor cells differentiated from human iPS and ES cells
$566,420Linzhao Cheng · Johns Hopkins University · RC2 · FY2009 · HL
Strategies for Cancer Vaccine Development: Preclinical Studies
$566,341Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Strategies for Therapeutic Cancer Vaccine Clinical Trials
$566,341Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
(PQ8) Predicting immune-related toxicity in the adjuvant melanoma setting with checkpoint inhibition
$566,338Iman Osman · New York University School Of Medicine · R01 · FY2020 · CA
Reproductive and Developmental Toxicity of Dioxin
$566,259Richard E Peterson · University Of Wisconsin-Madison · R01 · FY2012 · ES
Translation of a Bismuth-Gadolinium Nanoparticle for MR-guided Radiation Therapy
$566,253Ross I. Berbeco · Dana-Farber Cancer Inst · R01 · FY2024 · CA
CNS Gene Delivery and Imaging in brain Tumor Therapy
$566,207Edward A Neuwelt · Oregon Health & Science University · R01 · FY2006 · NS
Integrating Radiomics into S0819 and Lung-MAP, Biomarker Driven Clinical Trials for Lung Cancer
$566,084Lawrence H Schwartz · Sloan-Kettering Inst Can Research · U01 · FY2022 · CA
Integrative molecular and imaging approaches for risk of subtype specific breast
$566,060Randa A El-Zein · Methodist Hospital Research Institute · U01 · FY2016 · CA
Local Flavor Policies to Enhance Equity in Tobacco
$566,018Shyanika W Rose · University Of Kentucky · R01 · FY2021 · CA
PFI-RP: Precision diagnostics for personalized cancer care: development of new drugs and selection of treatment
$565,994Nancy L Guo · West Virginia University Research Corporation · · FY2023 · TIP
A Randomized Trial of Incentives for Research Participation
$565,976Scott D Halpern · University Of Pennsylvania · R01 · FY2019 · CA
Web-based Smoking Cessation Program for Tribal College Students
$565,964Won S Choi · University Of Kansas Medical Center · R01 · FY2015 · CA
Increasing Nodule Detection in Lung Cancer by Non-Conscious Detection of "Missed" Nodules and Machine Learning
$565,881Gregory James Digirolamo · Univ Of Massachusetts Med Sch Worcester · R01 · FY2025 · CA
Profiling genome-wide circulating ncRNAs for the early detection of lung cancer
$565,835Youping Deng · University Of Hawaii At Manoa · R01 · FY2018 · CA
Translating Autoantibodies Into Chimeric Antigen Receptor-T cell Therapy for Small Cell Lung Cancer
$565,815Kristin J Lastwika · Fred Hutchinson Cancer Center · U01 · FY2024 · CA
Technetium and Rhenium in Nuclear Medicine
$565,702Alun Gareth Jones · Harvard Medical School · R01 · FY2007 · CA
(7) Novel imaging devices for measurement and control of tumor microenvironments
$565,675John S Condeelis · Albert Einstein College Of Medicine, Inc · R01 · FY2017 · CA
The Boston University-UCLA Lung Cancer Biomarker Development Lab
$565,669Avrum E Spira · Boston University Medical Campus · U01 · FY2016 · CA